The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. (Record no. 24429325)

MARC details
000 -LEADER
fixed length control field 01423 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517005109.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201509s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2042-6984
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/alr.21443
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schaffer, Frederick M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150928
245 00 - TITLE STATEMENT
Title The safety of self-administered allergen immunotherapy during the buildup and maintenance phases.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International forum of allergy & rhinology
Date of publication, distribution, etc. Feb 2015
300 ## - PHYSICAL DESCRIPTION
Extent 149-56 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenergic alpha-Agonists
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Allergens
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Desensitization, Immunologic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epinephrine
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypersensitivity, Immediate
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patient Safety
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rhinitis, Allergic, Perennial
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rhinitis, Allergic, Seasonal
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Self Administration
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Naples, Andrew R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ebeling, Myla
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hulsey, Thomas C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garner, Larry M
773 0# - HOST ITEM ENTRY
Title International forum of allergy & rhinology
Related parts vol. 5
-- no. 2
-- p. 149-56
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/alr.21443">https://doi.org/10.1002/alr.21443</a>
Public note Available from publisher's website

No items available.